Oppenheimer & Co’s Broadridge BR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Sell
2,192
-1,574
-42% -$238K ﹤0.01% 1475
2026
Q1
$612K Sell
3,766
-193
-5% -$36.7K 0.01% 1097
2025
Q4
$884K Buy
3,959
+34
+0.9% +$7.75K 0.01% 853
2025
Q3
$935K Sell
3,925
-4
-0.1% -$996 0.01% 921
2025
Q2
$955K Sell
3,929
-56
-1% -$13.3K 0.01% 874
2025
Q1
$966K Buy
3,985
+109
+3% +$25.7K 0.01% 828
2024
Q4
$876K Sell
3,876
-971
-20% -$218K 0.01% 843
2024
Q3
$1.04M Buy
4,847
+180
+4% +$37.6K 0.02% 774
2024
Q2
$919K Sell
4,667
-123
-3% -$24.4K 0.01% 805
2024
Q1
$981K Buy
+4,790
New +$966K 0.02% 746
2021
Q1
Sell
-2,195
Closed -$336K 1440
2020
Q4
$336K Buy
+2,195
New +$318K 0.01% 1045
2020
Q1
Sell
-1,832
Closed -$226K 1206
2019
Q4
$226K Buy
1,832
+50
+3% +$6.11K 0.01% 1134
2019
Q3
$222K Sell
1,782
-225
-11% -$29K 0.01% 1093
2019
Q2
$256K Sell
2,007
-798
-28% -$96.1K 0.01% 1072
2019
Q1
$291K Buy
2,805
+582
+26% +$58.4K 0.01% 1046
2018
Q4
$214K Buy
+2,223
New +$241K 0.01% 1080

Other funds holding BR

Oppenheimer & Co's BR Position: Q2 2026 in Review

Oppenheimer & Co reduced its Broadridge (BR) stake by 42% in Q2 2026, selling an estimated $238K and leaving 2,192 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

Oppenheimer & Co first reported a position in BR in Q4 2018 and has held it in 16 quarters since. The position peaked at $1.04M in Q3 2024. 1,019 funds tracked by Wall St. Rank hold BR as of Q2 2026.

  • Oppenheimer & Co held 2,192 shares of Broadridge worth $300K as of Q2 2026.
  • Oppenheimer & Co sold 1,574 Broadridge shares in Q2 2026, an estimated $238K.
  • Broadridge made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1475 holding.
  • Oppenheimer & Co first reported a position in Broadridge in Q4 2018 and has held it in 16 quarters since.
  • Oppenheimer & Co's Broadridge position peaked at $1.04M in Q3 2024.
  • 1,019 funds tracked by Wall St. Rank held Broadridge as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.